Back to SNDX
Palo Alto Investors LP SNDX Position History
Syndax Pharmaceuticals, Inc. • Healthcare
Quarters held
6
Latest value
$11.2M
Q3 2026
Peak value
$20.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $16.7M |
| Q1 2026 | $20.2M |
| Q2 2026 | $18.9M |
| Q2 2026 | $18.9M |
| Q2 2026 | $18.9M |
| Q3 2026 | $11.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $11.2M | 596.4K | — | — |
| Q2 2026 | $18.9M | 865.0K | — | — |
| Q2 2026 | $18.9M | 865.0K | — | — |
| Q2 2026 | $18.9M | 865.0K | — | — |
| Q1 2026 | $20.2M | 865.0K | — | — |
| Q4 2025 | $16.7M | 794.5K | — | — |
Other funds holding SNDX
$188.1M
$169.2M
$153.2M
$123.7M
$123.7M
$118.9M
$116.1M